Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compliance with estrogen replacement therapy: current issues.

J Pitkin1

  • 1Northwick Park and St. Mark's Hospital, North West London NHS Trust, Faculty of Medicine, Imperial College, London, England.

Climacteric : the Journal of the International Menopause Society
|December 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double-blind placebo-controlled trial.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR).

International urogynecology journal·2013
Same author

Psychosocial adjustment in women with premature menopause: a cross-sectional survey.

Climacteric : the journal of the International Menopause Society·2012
Same author

The silent grief: psychosocial aspects of premature ovarian failure.

Climacteric : the journal of the International Menopause Society·2011
Same author

Menopause and urogynaecology service standards: a UK consultant-based questionnaire survey of RCOG recommendations.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2009
Same author

Management of menopausal symptoms associated with papillary carcinoma of thyroid.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2006

Improving hormone replacement therapy (HRT) adherence requires understanding women's perspectives and enhancing clinician communication. Addressing patient needs and offering diverse treatment options are key to long-term compliance in menopause management.

Area of Science:

  • Menopause management and hormone replacement therapy (HRT).

Background:

  • Compliance with HRT is a significant clinical challenge, with varying international uptake and continuation rates.
  • Conflicting literature exists regarding recent improvements in HRT adherence, highlighting the need for further investigation.
  • Understanding women's reasons for therapy cessation is crucial for improving long-term adherence.

Purpose of the Study:

  • To explore factors influencing compliance in menopause and hormone replacement management.
  • To bridge the gap between medical and feminist literature by examining women's viewpoints on HRT.
  • To identify strategies for enhancing patient-physician relationships and treatment individualization.

Main Methods:

  • Review of existing literature on HRT compliance, uptake, and cessation.

Related Experiment Videos

  • Analysis of market research insights into women's requirements for menopause management.
  • Examination of communication strategies, including counseling and information-giving.

    • Main Results:

    • Emerging factors positively influence long-term adherence to HRT.
    • Consistent reasons for therapy cessation are reported across studies.
    • Effective patient profiling and risk-benefit assessments necessitate physician education.

    Conclusions:

    • Enhanced communication skills, counseling, and information-giving are vital for building patient-physician relationships in HRT management.
    • Individualized risk-benefit assessments and patient profiling require adequate physician education.
    • A broader spectrum of treatment options can improve the individualization of HRT for women experiencing menopause.